ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Neonatology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1697565
Increasing Continuous Positive Airway Pressure Use Rates in the Delivery Room for Very Preterm Infants: A Quality Improvement Initiative
Provisionally accepted- 1Department of Pediatrics, Samsung Medical Center, Seoul, Republic of Korea
- 2Cell and Gene Therapy Institute for Future Medicine, Samsung Medical Center, Seoul, Republic of Korea
- 3Department of Health Science and Technology, Samsung Advanced Institute for Health Sciences & Technology, Seoul, Republic of Korea
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: In spontaneously breathing preterm infants, less invasive strategies, such as continuous positive airway pressure (CPAP) and less invasive surfactant administration, have been increasingly implemented to reduce lung injury. In 2018, our center initiated a noninvasive neonatal resuscitation protocol incorporating these approaches as quality improvement (QI) initiatives. We aimed to evaluate the feasibility, safety, and effectiveness of this protocol by comparing respiratory outcomes before and after its implementation. Methods: We retrospectively reviewed the medical records of 578 infants born at 25+0 to 29+6 weeks of gestation between 2014 and 2022 at Samsung Medical Center. Infants born in 2018 and those with severe congenital anomalies, delivery room deaths, or outborn status were excluded. The study population was divided into Period 1 (2014-2017, before noninvasive protocol implementation) and Period 2 (2019-2022, after protocol implementation) to assess the impact of QI initiatives on neonatal resuscitation practices. The year 2018 was excluded from the analysis as it represented a transitional period. We analyzed the rate of endotracheal intubation at birth and other respiratory outcomes, such as CPAP failure and bronchopulmonary dysplasia (BPD). Results: The rate of initial intubation was significantly lower in Period 2 than in Period 1 (77.0% vs 45.9%; adjusted odds ratio (aOR), 0.24; 95% confidence interval (CI), 0.15-0.40; P < 0.001), with declines observed across all gestational groups, particularly among infants ≥ 26 weeks' gestation. The rate of postnatal steroid use for BPD prevention was also significantly lower in Period 2 (50.0% vs 15.3%, aOR, 0.12; 95%, CI 0.07-0.21; P < 0.001). In Period 2, among 68 infants initially managed with CPAP during Period 2, 15 (22.1%) experienced CPAP failure within 48 h, and 24 (35.3%) experienced failure at any time during hospitalization. Despite these failures, no significant differences in the incidence of BPD, duration of invasive ventilation, or mortality were observed between the two periods. Conclusions: Our findings suggest that even in extremely preterm infants, a noninvasive resuscitation strategy is feasible, associated with reduced postnatal steroid use, and does not worsen major neonatal outcomes, supporting its use as a viable alternative for those who do not require immediate intubation.
Keywords: Continuous Positive Airway Pressure, Bronchopulmonary Dysplasia, intratrachealintubation, neonatal resuscitation, premature, Quality Improvement
Received: 02 Sep 2025; Accepted: 09 Oct 2025.
Copyright: © 2025 Kim, Lee, Kim, Kim, Choo, Yang, Ahn, Sung and Chang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Se In Sung, sein.sung@samsung.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.